MAP kinase activation by interleukin-9 in lymphoid and mast cell lines

Oncogene. 2003 Mar 27;22(12):1763-70. doi: 10.1038/sj.onc.1206253.

Abstract

Interleukin-9 (IL-9) stimulates the proliferation of mast cells and lymphocytes. In the present study, we showed that IL-9 induced a transient phosphorylation of MEK, ERK2 and p90/RSK in murine lymphoid and mast cell lines. ERK2 in vitro kinase activity was also increased upon IL-9 stimulation. Similar results were obtained with IL-4, which had not been previously reported to activate these kinases in hematopoietic cells. Analysis of IL-9 receptor mutants showed that activation of the pathway was correlated with proliferation and with phosphorylation of the adaptor protein SHC, but not IRS2 or GAB2. The MEK inhibitor PD98059 reduced the mitogenic response to IL-4 and IL-9. In addition, expression of a dominant-negative RAS variant blocked ERK phosphorylation and significantly decreased Ba/F3 cell growth in the presence of IL-9, but did not affect expression of pim-1, a STAT target gene. In summary, these results indicate that IL-9 can transiently activate the mitogen-activated protein kinase pathway, which contributes to growth stimulation of hematopoietic cell lines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • CHO Cells
  • Cell Line
  • Cricetinae
  • Enzyme Activation
  • Interleukin-9 / physiology*
  • Lymphoid Tissue / enzymology*
  • MAP Kinase Signaling System
  • Mast Cells / enzymology*
  • Mitogen-Activated Protein Kinases / metabolism*
  • Phosphorylation
  • Precipitin Tests

Substances

  • Interleukin-9
  • Mitogen-Activated Protein Kinases